SCHEMBL10125232

SCHEMBL10125232

C=C1[C@H](O)CC(=C/C=C2\CCCC3(C)C2CCC3[C@@H](C)OC[C@H](C)C(C)(C)C)C[C@H]1O

nearest known ligand 0.88

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 6/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13090316 0.94 VDR (1.00) VDR
SCHEMBL10125374 0.94 VDR (1.00) VDR
SCHEMBL29420212 0.94 VDR (1.00) VDR
SCHEMBL10125254 0.91 VDR (0.79) VDR
SCHEMBL10125236 0.88 VDR (0.69) VDR
SCHEMBL4168474 0.86 VDR (0.78) VDR
SCHEMBL13759523 0.86 VDR (0.75) VDR
SCHEMBL10152497 0.84 VDR (0.81) VDR
SCHEMBL10125228 0.83 VDR (0.77) VDR
SCHEMBL18059298 0.83 VDR (0.77) VDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115824-A1 Vitamin D Receptor Agonists and Uses Thereof VIDASYM, LLC (US) 2012-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115824-A1 Vitamin D Receptor Agonists and Uses Thereof VDR, CYP2R1, CYP24A1 VDR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback